Want to see AMTX full AI Analyst Report?
AMTX Stock Chart & Stats
$1.68
-$0.13(-7.72%)
At close: 4:00 PM EDT
$1.68
-$0.13(-7.72%)
Day’s Range― - ―
52-Week Range$1.30 - $3.80
Previous Close$1.6
Volume579.80K
Average Volume (3M)1.26M
Market Cap
$99.22M
Enterprise Value$746.98
Total Cash (Recent Filing)$4.80M
Total Debt (Recent Filing)$404.68M
Price to Earnings (P/E)―
Beta1.04
Next Earnings
Aug 06, 2026EPS Estimate
-0.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.19
Shares Outstanding70,366,480
10 Day Avg. Volume1,109,950
30 Day Avg. Volume1,263,025
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)-0.30
Price to Sales (P/S)0.44
P/FCF Ratio-4.02
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$25.00Price Target Upside1388.10% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-1.01
Revenue Forecast (FY)$284.71M
Bulls Say, Bears Say
Bulls Say
Top-line Growth Across SegmentsSustained 27% YoY revenue growth across all reportable segments indicates expanding commercial adoption and diversified sales channels. Over 2-6 months this supports higher operating leverage potential, improves bargaining power with suppliers/customers, and underpins future scale-driven margin improvements if trends persist.
Improving Unit Economics And MarginsA return to positive gross profit and a ~60% improvement in operating loss reflect structural cost, mix and operational fixes rather than one‑off gains. If maintained, this trajectory signals the business moving toward sustainable margin profile and weaker reliance on extraordinary credits to mask operating performance.
Keyes MBR/MVR Project Adds Durable Cash FlowAimed $32M annual cash flow uplift from the Keyes mechanical vapor compression/MBR projects represents a structural improvement to operating cash generation. Successful commissioning would reduce cash burn, improve free cash flow sustainability and materially de‑risk project financing needs over the medium term.
Bears Say
Highly Leveraged Balance SheetDebt materially exceeding assets and deeply negative equity indicate constrained financial flexibility and elevated solvency risk. Over months, this structure raises refinancing exposure, increases interest burdens, and makes the company sensitive to project timing and credit market swings, complicating durable capital allocation.
Weak And Negative Free Cash FlowPersistently negative FCF and operating cash drains mean the business depends on external funding or asset monetization to sustain capex and growth. This undermines medium‑term self‑funding of expansion, raises dilution or refinancing risks, and limits the firm's ability to absorb delays in project commissioning or credit monetization.
Dependence On Regulatory Timing For FinancingKey projects and credit valuation depend on timely regulatory updates (45z GREET, LCFS pathways). This creates structural execution risk: delayed approvals impede financing, postpone cash flow realization, and extend the time until projects de‑risk, making multi‑month funding and operational plans fragile.
AMTX FAQ
What was Aemetis Inc’s price range in the past 12 months?
Aemetis Inc lowest stock price was $1.30 and its highest was $3.80 in the past 12 months.
What is Aemetis Inc’s market cap?
Aemetis Inc’s market cap is $99.22M.
When is Aemetis Inc’s upcoming earnings report date?
Aemetis Inc’s upcoming earnings report date is Aug 06, 2026 which is in 6 days.
How were Aemetis Inc’s earnings last quarter?
Aemetis Inc released its earnings results on May 07, 2026. The company reported -$0.33 earnings per share for the quarter, missing the consensus estimate of -$0.284 by -$0.046.
Is Aemetis Inc overvalued?
According to Wall Street analysts Aemetis Inc’s price is currently Undervalued.
Does Aemetis Inc pay dividends?
Aemetis Inc does not currently pay dividends.
What is Aemetis Inc’s EPS estimate?
Aemetis Inc’s EPS estimate is -0.26.
How many shares outstanding does Aemetis Inc have?
Aemetis Inc has 70,366,480 shares outstanding.
What happened to Aemetis Inc’s price movement after its last earnings report?
Aemetis Inc reported an EPS of -$0.33 in its last earnings report, missing expectations of -$0.284. Following the earnings report the stock price went down -3.704%.
Which hedge fund is a major shareholder of Aemetis Inc?
Currently, no hedge funds are holding shares in AMTX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Aemetis Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$25.00 (1388.10% Upside)
$25.00 (1388.10% Upside)
Blogger Sentiment
Bullish
AMTX Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 32.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $20.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 3.6%
Last 30 Days ▼ 3.6%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-51.25%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
11.47%
Trailing 12-Months
Company Description
Aemetis Inc
Aemetis, Inc. is an enterprise specializing in renewable natural gas and sustainable fuels, conducting operations across North America and India. The company's business activities are structured into three primary divisions: California Ethanol, Dairy Renewable Natural Gas, and India Biodiesel. A core objective for Aemetis is the procurement, development, and market launch of innovative products and technologies that offer negative carbon intensity, serving as eco-friendly alternatives to traditional petroleum-based goods. Its biodiesel products are distributed to a diverse range of customers, including government oil marketing agencies, transportation companies, various resellers, distributors, and private refiners. These sales are facilitated through both its in-house sales team and independent sales agents, as well as via brokers who then supply end-users. Beyond biodiesel, the company also produces and markets ethanol. Furthermore, Aemetis creates and supplies valuable co-products for animal feed, such as wet distillers grains, distillers corn oil, and condensed distillers solubles, to dairies and feedlots. The company's offerings also encompass the generation of dairy biogas, the production and sale of high-grade alcohol, various feed products, and hand sanitizers. Aemetis actively invests in research and development, particularly focusing on advanced conversion technologies that transform waste feedstocks into biofuels and biochemicals. Founded in 2005, the company initially operated as AE Biofuels, Inc. before officially adopting the name Aemetis, Inc. in November 2011. Its corporate headquarters are located in Cupertino, California.
AMTX Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a clear operational and financial inflection: strong top-line growth (+27%), return to positive gross profit, meaningful operating loss improvement (~60%), and tangible project progress (LCFS pathway approvals, dairy RNG expansion, Keyes MVR equipment on-site). Management also highlighted significant near-term catalysts (45z GREET update, MBR commissioning, rising LCFS prices, India IPO) that could materially improve cash flow and margins. However, the company still reports negative adjusted EBITDA and a net loss, has modest cash on hand ($4.8M), and faces financing and policy timing risks—notably for the large RD/SAF project and full realization of LCFS/45z-related uplift. On balance, the positives and actionable catalysts outweigh the risks outlined, but execution and regulatory clarity remain critical.View all AMTX earnings summariesAMTX Stock 12 Month Forecast
Average Price Target
$25.00
▲(1388.10% Upside)
Technical Analysis
Ownership Overview
7.13% Insiders
5.84% Mutual Funds
0.72% Other Institutional Investors
77.83% Public Companies and Individual Investors










